These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10824545)

  • 21. Neuroendocrine tumors of the lung. Pathology and molecular biology.
    Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
    Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.
    Murakami Y
    Oncogene; 2002 Oct; 21(45):6936-48. PubMed ID: 12362275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel molecular and immunotherapeutic strategies for lung cancer.
    Pass HI; Kalemkerian G; Bright RK
    Chest Surg Clin N Am; 2001 Feb; 11(1):189-212, ix. PubMed ID: 11253598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relations of tumor suppressor gene p16 and RB to early diagnosis of lung cancer.
    Ye Y; Su C; Wang D; Guo W; Cheng X; Liu S; Liu Y; Liu B; Cao X; Shan X; Wu M
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):885-9. PubMed ID: 11832187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prospective views for molecular oncology of the lung].
    Ebina M; Nukiwa T
    Nihon Rinsho; 1996 Feb; 54(2):299-303. PubMed ID: 8838072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
    Tessema M; Willink R; Do K; Yu YY; Yu W; Machida EO; Brock M; Van Neste L; Stidley CA; Baylin SB; Belinsky SA
    Cancer Res; 2008 Mar; 68(6):1707-14. PubMed ID: 18339850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pathology of lung cancer.
    Wistuba II; Gazdar AF
    Verh Dtsch Ges Pathol; 2000; 84():96-105. PubMed ID: 11217455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.
    Digel W; Lübbert M
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):1-11. PubMed ID: 15886007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers].
    Grote HJ; Schmiemann V; Böcking A
    Verh Dtsch Ges Pathol; 2003; 87():142-9. PubMed ID: 16888906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational research in lung cancer.
    Chen Y; Okunieff P; Ahrendt SA
    Semin Surg Oncol; 2003; 21(3):205-19. PubMed ID: 14508854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Esteller M; Sanchez-Cespedes M; Rosell R; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 1999 Jan; 59(1):67-70. PubMed ID: 9892187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology of lung cancer with implications for new therapies.
    Aberle MF; McLeskey SW
    Oncol Nurs Forum; 2003; 30(2):273-80. PubMed ID: 12692661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the understanding of lung cancer.
    Groeger AM; Esposito V; Mueller MR; Caputi M; Kaiser HE; Giordano A
    Anticancer Res; 1997; 17(4A):2519-22. PubMed ID: 9252673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for lung cancer.
    Toloza EM; Morse MA; Lyerly HK
    J Cell Biochem; 2006 Sep; 99(1):1-22. PubMed ID: 16767697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.